Epilepsy Drugs Market Size And Share

  • Report Code : TIPRE00024323
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 139
Buy Now

Epilepsy Drugs Market Size, Share, and Forecast by 2031

Buy Now

Epilepsy Drugs Market Report Epilepsy Drugs Market Scope and Analysis Epilepsy Drugs Market Size and Share

Epilepsy Drugs Market: Strategic Insights

Epilepsy Drugs Market

  • CAGR (2022 - 2030)
    4.1%
  • Market Size 2022
    US$ 7.7 Billion
  • Market Size 2030
    US$ 10.7 Billion

Market Dynamics

GROWTH DRIVERS
  • Rising Incidence of Epilepsy Cases Accelerate Demand for Antiepileptic Drugs to Favor Market
FUTURE TRENDS
  • Rising Research & Development (R&D) activities are likely to remain key trends in the market
OPPORTUNITIES
  • Rising Clinical Trials for Epilepsy Drugs Provide Lucrative Market Opportunity

Key Players

  • UCB SA
  • Novartis AG
  • Pfizer
  • GSK
  • Abbott
  • Sanofi
  • Sumito Pharma Company
  • Teva Pharmaceuticals
  • Catalyst Pharmaceuticals
  • Alkem Laboratories

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Treatment
  • First-Generation Anti-Epileptics
  • Second Generation Anti-Epileptics
  • Third Generation Anti-Epileptics
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies